XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash Flows from Operating Activities    
Net income $ 2,330 $ 2,179
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation, amortization and accretion, net (125) (114)
Deferred income tax expense (benefit) 169 106
Share-based compensation 138 138
Net realized investment (gains) losses 0 47
Net trading (gains) losses (5) (6)
Loss from equity method investments 13 19
Impairments and provision for loan and credit losses 5 (15)
Net (gains) losses of consolidated investment entities 5 18
Changes in operating assets and liabilities:    
Restricted and segregated investments (2) (107)
Deferred acquisition costs 27 52
Policyholder account balances, future policy benefits and claims, and market risk benefits, net 3,445 1,231
Derivatives, net of collateral (1,168) (431)
Receivables 221 324
Brokerage deposits 245 (615)
Accounts payable and accrued expenses (27) 64
Current income tax, net 174 (338)
Other operating assets and liabilities of consolidated investment entities, net 1 (8)
Other, net 766 (2)
Net cash provided by (used in) operating activities 6,212 2,542
Available-for-Sale securities:    
Proceeds from sales 1,810 726
Maturities, sinking fund payments and calls 11,136 6,660
Purchases (12,626) (15,194)
Proceeds from sales, maturities and repayments of mortgage loans 128 108
Funding of mortgage loans (309) (187)
Proceeds from sales, maturities and collections of other investments 102 115
Purchase of other investments (153) (73)
Purchase of investments by consolidated investment entities (791) (347)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities 700 492
Purchase of land, buildings, equipment and software (118) (134)
Cash paid for written options with deferred premiums (57) (59)
Cash received from written options with deferred premiums 22 43
Cash paid for deposit receivables (25) (30)
Cash received for deposit receivables 470 579
Other, net (57) (41)
Net cash provided by (used in) investing activities 232 (7,342)
Investment certificates:    
Proceeds from additions 3,883 8,572
Maturities, withdrawals and cash surrenders (5,353) (5,279)
Policyholder account balances:    
Deposits and other additions 1,094 1,033
Net transfers from (to) separate accounts (124) (89)
Surrenders and other benefits (1,385) (1,539)
Change in banking deposits, net 233 2,666
Cash paid for purchased options with deferred premiums (122) (49)
Cash received for purchased options with deferred premiums 181 251
Issuance of long-term debt, net of issuance costs 0 741
Repayments of long-term debt (8) (8)
Dividends paid to shareholders (430) (414)
Repurchase of common shares (1,783) (1,660)
Borrowings of consolidated investment entities 883 0
Repayments of debt by consolidated investment entities (778) (197)
Other, net 2 2
Net cash provided by (used in) financing activities (3,707) 4,030
Effect of exchange rate changes on cash 22 6
Net increase (decrease) in cash and cash equivalents, including amounts restricted 2,759 (764)
Cash and cash equivalents, including amounts restricted, at beginning of period 8,620 8,755
Cash and cash equivalents, including amounts restricted, at end of period 11,379 7,991
Supplemental Disclosures:    
Income taxes paid, net 215 796
Leased assets obtained in exchange for operating lease liabilities 23 58
Ameriprise Financial    
Supplemental Disclosures:    
Interest paid 614 438
Consolidated investment entities    
Supplemental Disclosures:    
Interest paid $ 126 $ 132